Terminated NA INTERVENTIONAL 1-arm
NCT00331708
Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria
An Open-label in Vivo Drug Study to Evaluate Artesunate Plus Sulfadoxine-pyrimethamine (ASSP) Pharmacokinetics, Therapeutic Efficacy, Gametocyte Carriage and Birth Outcomes in Pregnant Women With Uncomplicated Falciparum Malaria
Sponsor: Global Fund
Conditions
Malaria
Interventions
Artesunate plus sulfadoxine-pyrimethamine
Updated 1 time since 2024 Last updated: Oct 25, 2016 Started: Apr 30, 2006 Primary completion: Jul 31, 2007 Completion: Jul 31, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Terminated
Lack of suitable participants
A NA clinical study on Malaria, this trial is terminated or withdrawn. The trial is conducted by Global Fund and has accumulated 1 data snapshot since 2006. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
1 version recorded Terminated — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Global Fund
- Medical Research Council, South Africa
- Professor Karen I Barnes
Data source: University of Cape Town
For direct contact, visit the study record on ClinicalTrials.gov .